Chief Executive Officer and Director at Immunovant, Inc.
Peter Salzmann, M.D., M.B.A, is the Chief Executive Officer of Immunovant and a member of our board of directors. From November 2018 to June 2019, he served as a Global Brand Development Leader in Immunology at Eli Lilly and Company, where he was responsible for the design of a comprehensive indication strategy and oversaw Phase 2 and 3 clinical trial execution. From March 2013 to October 2018, Dr. Salzmann was Head of U.S. Immunology at Eli Lilly, and he also served as Managing Director of Lilly Alps from January 2011 to April 2013. From January 2008 to December 2010, Dr. Sal... Read more
Source: Immunovant, Inc. on 09/11/2023
By accessing ExecAtlas, you can view bios, network, connections and references of industry leading executives like Peter Salzmann M.D.. More specifically, you'll be able to:
Access over 2,000,000 executive and board member profiles.
Example: Peter Salzmann M.D.